Publications by authors named "Toyohiro Hashiba"
Article Synopsis
- The study aimed to assess the effectiveness of COVID-19 vaccines in Japanese patients on haemodialysis, using data from a comprehensive national registry covering about 95% of this population.
- Researchers analyzed data from 228,865 patients and found that vaccinated individuals had significantly lower rates of COVID-19 infections and related mortality, particularly in the months of August to November 2021.
- The findings indicate that receiving one or two doses of the COVID-19 vaccine substantially reduced the risk of infection and death from the virus among patients undergoing haemodialysis.
Aim: It remains undetermined whether online education videos for Japanese patients with chronic kidney disease (CKD) are easy to understand and allow adoption of behavioural changes. This study quantitatively assessed the understandability and applicability of online education videos for patients with CKD.
Methods: In September 2021, we identified 200 videos on YouTube using the Japanese translations of the keywords 'kidney,' 'kidney disease,' 'CKD,' and 'chronic kidney disease.
Paralytic ileus as tuberculosis-immune reconstitution inflammatory syndrome (TB-IRIS) is extremely rare. We herein report a 44-year-old man with pulmonary and renal tuberculosis who developed paralytic ileus 14 days after starting antituberculosis therapy (ATT) despite an initial favorable response to ATT. Paralytic ileus was successfully managed with conservative care.
View Article and Find Full Text PDFProliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) generally has a poor prognosis and the consensus is that it needs to be treated with clone-directed therapy. However, the prognosis of PGNMID is heterogenous and some cases have been successfully treated using other therapeutic strategies. We herein report a case of PGNMID that responded favorably to steroids without clone-directed therapy.
View Article and Find Full Text PDFBackground: Transcatheter arterial chemoembolization (TACE) is widely used for unresectable hepatocellular carcinoma (HCC). The purpose of this study was to investigate incidence and risk factors of contrast-induced nephropathy (CIN) after TACE in patients with HCC.
Methods: In this single-center retrospective study, we examined 461 consecutive TACE sessions in 260 patients between January 2003 and October 2015.